Next Generation of Lung Cancer Management
A look at the latest lung cancer research, recent advances in the field and their clinical applications.
Classifying DLBCL Subtypes for Optimal Treatment
Jennifer Crombie, MD, discusses classification of diffuse large B-cell lymphoma (DLBCL) into distinct subtypes and treatment decisions based on molecular classifications.
Mutations and the Importance of Genetic Testing
Dr. Allison W. Kurian discusses a new breast cancer study that analyzed the mutations present in breast tumors, and about emerging targeted therapy options.
Immunotherapy in Colorectal Cancer
Immune checkpoint inhibitors have demonstrated impressive activity in patients with CRC and other solid tumors that are dMMR. Researchers explore the data.
Immunotherapy Advances: 2019
This year has seen many advances in immunotherapy. Here is a look at some of the most significant research.
Metastasis-Directed Therapy in Prostate Cancer. Why, When, and How?
Metastasis-directed therapy with stereotactic ablative radiotherapy has emerged as a promising complementary technique for the management of low-volume metastatic prostate cancer.
Personality Disorders in Patients with Cancer
Personality disorders become exacerbated under stressful cancer-related situations and may lead to adverse consequences and outcomes.
